STAT News

OCTOBER 25, 2022

The antitrust regulator in Spain has fined Merck approximately $39 million for preventing a competitor from marketing a generic version of a hormonal contraceptive, the latest effort by a European government to crack down on anti-competitive practices in the pharmaceutical industry. Continue to STAT+ to read the full story…

Regulation 98

Regulation Hormones Manufacturing Production 98

Drug Discovery World

JUNE 1, 2023

A Nature publication confirmed that there are currently 12 FDA-approved ADCs on the market, and nine of these secured FDA approval in the past six years 2. DDW’s Megan Thomas explores three trends in the market. Varying sources suggest that China has been one to watch over recent years and continues to be going forward.

Antibody 98

Antibody Marketing Drugs Licensing 98

XTalks

JANUARY 9, 2024

The thyroid plays a critical role in the body by producing hormones that regulate metabolism, heart rate and body temperature among others. Types of Thyroid Conditions There are several different thyroid conditions, with each affecting thyroid hormone production or the gland’s structure, leading to a range of health issues.

Hormones 105

Hormones Antibody Trials Production 105

pharmaphorum

APRIL 1, 2022

market is just beginning to heat up. And with the availability of two versions—a branded and unbranded version—the industry will watch closely how both products compete in the commercial market versus Medicare Part D plans, and whether any other insurers adopt it to their formularies.

Marketing 59

Marketing Pharmacy FDA Approval Manufacturing 59

Pharmaceutical Technology

MAY 31, 2023

Les Laboratoires Servier overview Les Laboratoires Servier (Servier) researches, develops, manufactures, and markets drugs for treating various diseases. The company also provides generic drugs and contract development and manufacturing services across its global network.

Generic Drugs 100

Generic Drugs Hormones Manufacturing Development 100

Pharmaceutical Technology

MAY 25, 2023

Mellozzan contains the sleep hormone melatonin and is indicated for use in children with attention deficit hyperactivity disorder (ADHD) and sleep difficulties. EQL Pharma will serve as manufacturer and supplier of the therapy for all third-party deals signed by Adalvo.

Hormones 130

Hormones Engineer Licensing Licensing 130

BioTech 365

OCTOBER 14, 2020

… Continue reading →

Manufacturing 40

Manufacturing Production Marketing Hormones 40

Roots Analysis

OCTOBER 24, 2023

Owing to the advancement in clinical pharmacology and oncology domain, and the rising demand for targeted therapeutics and precision medicines, high potency active pharmaceutical ingredients (HPAPIs) and cytotoxic drugs have become one of the key areas of interest to researchers and drug manufacturers across the globe.

Manufacturing 40

Manufacturing Hormones Contamination Containment 40

pharmaphorum

MAY 20, 2021

NICE has rejected Johnson & Johnson’s oral prostate cancer drug Erleada (apalutamide) in patients with hormone-relapsed or hormone sensitive disease in first draft guidance. Hormone relapsed disease has stopped responding to hormone therapy and is usually treated with ADT alone or with Bayer’s Nubeqa (darolutamide) and ADT.

Hormones 98

Hormones Drugs Trials Manufacturing 98

Pharmaceutical Technology

FEBRUARY 24, 2023

Douglas Pharmaceuticals overview Douglas Pharmaceuticals (Douglas) carries out the development and manufacture of nutraceutical and health products. The company also offers contract manufacturing and laboratory services. The company offers consumer, prescription and automation products.

Contract Manufacturing 100

Contract Manufacturing Dermatology Hormones Production 100

Pharmaceutical Technology

FEBRUARY 24, 2023

Douglas Pharmaceuticals overview Douglas Pharmaceuticals (Douglas) carries out the development and manufacture of nutraceutical and health products. The company also offers contract manufacturing and laboratory services. The company offers consumer, prescription and automation products.

Contract Manufacturing 100

Contract Manufacturing Dermatology Hormones Production 100

Pfizer

JANUARY 27, 2023

Contraception: Use of ritonavir may reduce the efficacy of combined hormonal contraceptives. Advise patients using combined hormonal contraceptives to use an effective alternative contraceptive method or an additional barrier method of contraception.

Marketing 75

Marketing Production Drugs Licensing 75

XTalks

JANUARY 23, 2024

Pediatric growth hormone deficiency (PGHD) is one such condition, affecting a child’s growth and development. This rare endocrine disorder, characterized by inadequate secretion of growth hormone from the pituitary gland, has profound impacts on physical and sometimes cognitive development.

Development 72

Development Hormones Drugs Trials 72

Roots Analysis

JANUARY 23, 2024

The peptide therapeutics market has undergone substantial evolution since the inception of insulin. Presently, over 80 peptide-based drugs are available in the market for myriad of disorders and diseases. Presently, over 80 peptide-based drugs are available in the market for myriad of disorders and diseases.

Development 40

Development Contract Manufacturing Drugs Manufacturing 40

pharmaphorum

SEPTEMBER 6, 2022

The health technology assessment (HTA) authority said that the PARP inhibitor “is not cost-effective at its current price” as a treatment for BRCA-positive prostate cancer that has spread to other parts of the body and relapsed after prior hormonal therapy.

Hormones 112

Hormones Drugs Manufacturing Research 112

XTalks

JANUARY 24, 2022

Fooditive Group , a plant-based ingredient manufacturer, recently developed a vegan version of casein, one of the main animal proteins in milk. In developing the vegan casein, Fooditive aims to eradicate the downsides of factory farming, antibiotics, hormones and lactose. So, what is casein?

Gene Splicing 112

Gene Splicing Protein Hormones Production 112

Fossil Remedies

APRIL 7, 2020

Having headquarters in Ahmadabad, Gujarat, ‘ Fossil Remedies ’ is the top most Pharma franchises company in India with long years of experience.They manufacture and market more than 2800+ Pharma products and indulge in 8 Special divisions. 100+ Gynec & Hormones Products. They offer pharma franchise to interested parties.

Pharma Production 81

Pharma Production Pharma Companies Production Contract Manufacturing 81

XTalks

SEPTEMBER 28, 2023

The discrepancy lies in the fact that American food manufacturers can use additives that are banned in Europe due to their associated significant health risks. This meant manufacturers could skip the FDA’s exhaustive safety review process, ensuring their products reached the market faster.

Hormones 52

Hormones Containment Production Cosmetics 52

pharmaphorum

JULY 29, 2021

The UK has levied another big fine for anticompetitive activity in the pharma market in a fortnight, with Advanz Pharma and former owners on the hook for more than £100 million ($140 million) after increasing the price of a thyroid disease drug by 1,110% over an eight-year period. ” Advanz itself was directly fined £40.9

Drugs 98

Drugs Marketing Generic Drugs Hormones 98

FDA Law Blog

AUGUST 4, 2023

So, through DASCA, Congress targeted those who would circumvent the Controlled Substances Act (“CSA”) by manufacturing anabolic steroids with slightly different chemical structures from those expressly controlled by the CSA but which are intended to cause the same potentially harmful effects. at 50,039 codified at 21 C.F.R.

Hormones 52

Hormones Manufacturing Regulation Drugs 52

Pharmaceutical Technology

SEPTEMBER 23, 2022

For pharma and biotech companies, there are many advantages to partnering with a Contract Development and Manufacturing Organisations (CDMO): they can access more specialized knowledge, state-of-the-art equipment, and qualified staff, as well as reduce their total cost of ownership, all while maintaining speed to market.

Manufacturing 147

Manufacturing Drugs Production Packaging 147

XTalks

NOVEMBER 3, 2022

Although the company is planning to double capacity through a new manufacturing expansion in North Carolina planned for the end of 2023, company executives are warning of supply challenges. In its first quarter on the market since its approval, sales totalled $97 million between July and September in the US.

Sales 98

Sales FDA Approval Production Insulin 98

Pharmaceutical Technology

FEBRUARY 14, 2023

The company filed heterocyclic composition patents in areas such as PAD4 inhibitors, factor Xa inhibitors, and nuclear hormone receptor modulators. Its primary focus is on cancer, cardiovascular, immunology and fibrotic therapeutic projects. Its primary focus is on cancer, cardiovascular, immunology and fibrotic therapeutic projects.

Antibody 130

Antibody Hormones DNA Licensing 130

pharmaphorum

AUGUST 11, 2021

After rejecting Eli Lilly’s Verzenio for breast cancer therapy earlier this year, NICE has relented, recommending the drug for routine NHS use alongside hormonal therapy fulvestrant. The February decision to reject the twice-daily drug was described as a “devastating blow” by patient advocacy group Breast Cancer Now.

Hormones 65

Hormones Drugs Clinical Trials Clinical Trials 65

pharmaphorum

NOVEMBER 27, 2022

Incidents such as the hormone replacement therapy drug shortage in early 2022 have shown the damaging impact supply chain issues can have on people who depend on these drugs. This means batch sizes can be tailored to daily demands rather than market forecasts. End-to-end monitoring for maximum security. About the author.

Production 106

Production Manufacturing Drugs Marketing 106

The Pharma Data

APRIL 13, 2022

Food and Drug Administration (FDA) provided notice to the companies that the agency identified deficiencies that preclude discussion of labeling and/or post-marketing requirements and commitments at this time. In accordance with the ongoing review of the application, on April 6, 2022, the U.S. The FDA did not provide additional detail.

Drugs 52

Drugs Hormones Medicine Production 52

XTalks

NOVEMBER 9, 2023

Zepbound contains mimetics of the GLP-1 and GIP hormones that regulate appetite and blood sugar. Both Novo and Lilly have been struggling on the manufacturing end amid growing demand for their GLP-1 agonists. The companies continue to roll out manufacturing expansion plans to help ramp up production.

FDA Approval 59

FDA Approval Manufacturing Drugs Pharmacy 59

Roots Analysis

MARCH 21, 2022

Subcutaneous biologics – current market landscape. Medical device manufacturers have developed a diverse range of products that can enable subcutaneous delivery of various injectable therapies. There are a variety of biologically derived therapeutics that are presently available / being developed. Our Social Media Platform.

Drug Delivery Systems 52

Drug Delivery Systems Drug Delivery Antibody Marketing 52

Delveinsight

DECEMBER 29, 2020

Myovant Sciences have decided to put their forces and efforts together to advance the Prostate cancer market as they announced their partnership deal to develop and market relugolix for prostate cancer and women’s health. . Relugolix is a once-daily, oral gonadotropin-release hormone (GnRH) receptor antagonist.

Trials 52

Trials Drugs Hormones Radiology 52

The Pharma Data

DECEMBER 16, 2020

market for this product is approximately $12.7 “This is ANI’s seventh generic product launch in 2020 and reaffirms our commitment to increasing the pace of market introductions for our products. Food and Drug Administration (FDA) approval and the launch of Aminocaproic Acid Tablets USP, 500mg. The current annual U.S.

Production 52

Production Contract Manufacturing Manufacturing Marketing 52

Fossil Remedies

JUNE 18, 2020

PCD Pharma Companies are those companies, which provides products to its franchise partners and also distributorship rights and monopoly of marketing for the given geographic area or location. 100+ Gynec & Hormones Products. 100+ Gynec & Hormones Products. PCD Pharma means Propoganda Distribution. Fossil Remedies.

Pharma Companies 52

Pharma Companies Production Marketing Branding 52

STAT News

DECEMBER 5, 2022

Food and Drug Administration is taking a harder line on its program that fast-tracks drug approvals based on preliminary evidence, spurring GSK, Roche, and others to remake plans for their drugs or pull them from the market , The Wall Street Journal notes. Wade, and the lawsuit is seen by both sides as the start of the battle to come.

Insulin 52

Insulin Manufacturing Medicine Drugs 52

XTalks

OCTOBER 24, 2023

Classified as GLP-1 drugs, Wegovy and Ozempic replicate a hormone that signals fullness to the brain, pushing people, even those on diabetes medications, to consume less and opt for healthier dietary selections. Before diving deeper into the potential effects on the food industry, let’s first understand these drugs.

Drugs 59

Drugs Hormones Pharmacy Production 59

Drug Discovery World

SEPTEMBER 7, 2022

The PROfound trial, led by researchers at the ICR and The Royal Marsden NHS Foundation Trust, showed that in men with faulty DNA repair genes olaparib blocked prostate cancer growth more effectively than modern hormone treatments. It is now urging NICE to work with the manufacturer to make olaparib available.

Genetics 52

Genetics Drugs DNA Gene 52

XTalks

MARCH 8, 2024

Despite the approvals, the market launches of Jubbonti and Wyost are uncertain due to ongoing patent litigation between Sandoz and Amgen. Amgen also claimed that Sandoz failed to provide information about its biosimilar manufacturing process as required by law.

Drugs 59

Drugs FDA Approval Production Immune Response 59

Druggist

JULY 20, 2020

Today I am looking at different options for treatment of Hormone Replacement Therapy (HRT), focusing on Evorel, Evorel Conti and Evorel Sequi alternative drugs. Theramex committed to increase manufacturing of Evorel products by investing in an additional manufacturer and additional packaging equipment.

Pharmacy 59

Pharmacy Drugs Containment Production 59

The Pharma Data

AUGUST 30, 2021

Key abstracts accepted by ESMO include: Overall survival (OS) results from the phase III MONALEESA-2 (ML-2) trial of postmenopausal patients with hormone receptor positive/human epidermal growth factor receptor 2 negative (HR+/HER2?) 19, 2:10 PM CEST]. Prostate Cancer. 177 Lu-PSMA-617. Abstract presentation # 647TiP. 16, 08:30 AM CEST.

HR 52

HR Production Trials Containment 52